Theravance, Inc.
NASDAQ: THRX
$7.72
-$0.34 (-4.2%)
Closing price March 30, 2023
We are seeing many key movers in the BioHealth space today as drug and biotech stocks often exhibit the most volatility of any sector. Today’s BioHealth Business Daily includes the key moves and...
13 years ago
Last Updated: 2 years ago
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
13 years ago
Last Updated: 3 years ago
These are some of the top pre-market analyst upgrades and positive calls from Wall Street this Thursday morning: AEterna Zentaris (AEZS) Raised to Outperform at RBC. Akamai Tech (AKAM) Raised to Buy...
14 years ago
Last Updated: 2 years ago
Many biotech stocks are enjoying large gains Monday, although some are on no real breaking news. Here is a look at some notable gainers: Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) up $1.39 to $28.97,...
15 years ago
Some of these stocks hit 52-week lows and recovered off of lows so they won’t have a low close. But these did all touch or breach the 52-week lows. At the end we also broke out...
15 years ago
Last Updated: 3 years ago
(AA) Alcoa $0.81 EPS vs $0.81e; will likely have to sweeten Alcan bid before getting any approval from Alcan.(BOT) CBOT holders approve the CME merger offer.(CACS) Carrier Access lowered...
15 years ago